Shih-Wei Lai. Proton Pump Inhibitors and Fracture Risk. Am J Gastroenterol 2019;114:1693
Yi-Chao Shi, Shun-Tian Cai, Ya-Ping Tian, Hui-Jun Zhao, Yan-Bing Zhang, Jing Chen, Rong-Rong Ren, Xi Luo, Li-Hua Peng, Gang Sun, Yun-Sheng Yang. Effects of Proton Pump Inhibitors on the Gastrointestinal Microbiota in Gastroesophageal Reflux Disease. 2019;17:52
Miltiadis A Makrygiannakis, Eleftherios G Kaklamanos, Athanasios E Athanasiou. Does common prescription medication affect the rate of orthodontic tooth movement? A systematic review. 2018;40:649
Young Ho Shin, Hyun Sik Gong, Goo Hyun Baek. Lower Trabecular Bone Score is Associated With the Use of Proton Pump Inhibitors. Journal of Clinical Densitometry 2019;22:236
Li-Yuan Yu, Lu-Ning Sun, Xue-Hui Zhang, Yue-Qi Li, Lei Yu, Zi-Qing-Yun Yuan, Ling Meng, Hong-Wen Zhang, Yong-Qing Wang. A Review of the Novel Application and Potential Adverse Effects of Proton Pump Inhibitors. Adv Ther 2017;34:1070
Shahab Abtahi, Johanna H M Driessen, Andrea M Burden, Patrick C Souverein, Joop P van den Bergh, Tjeerd P van Staa, Annelies Boonen, Frank de Vries. Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study. Annals of the Rheumatic Diseases 2021;80:423
Maria Fusaro, Graziella D'Arrigo, Annalisa Pitino, Giorgio Iervasi, Francesca Tentori, Bruce Robinson, Andrea Aghi, Brian Bieber, Keith Mccullogh, Fabrizio Fabris, Mario Plebani, Sandro Giannini, Maurizio Gallieni, Giovanni Tripepi. Increased Risk of Bone Fractures in Hemodialysis Patients Treated with Proton Pump Inhibitors in Real World: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). 2019;34:2238
Nathan Fleishman, Troy Richardson, Thomas Attard. The Clinical Characteristics of Fractures in Pediatric Patients Exposed to Proton Pump Inhibitors. J. pediatr. gastroenterol. nutr. 2020;70:815
Berna Saygın Hekimoğlu. Risk factors and clinical features of osteopenia of prematurity: Single-center experience. Trends in Pediatrics 2023;4:24
Salman Hussain, Ali Nasir Siddiqui, Anwar Habib, Md. Sarfaraj Hussain, Abul Kalam Najmi. Proton pump inhibitors’ use and risk of hip fracture: a systematic review and meta-analysis. Rheumatol Int 2018;38:1999
Wei-Te Hung, Ying-Hock Teng, Shun-Fa Yang, Han-Wei Yeh, Ying-Tung Yeh, Yu-Hsun Wang, Ming-Yung Chou, Ming-Chih Chou, Chi-Ho Chan, Chao-Bin Yeh. Association between Proton Pump Inhibitor Use and CNS Infection Risk: A Retrospective Cohort Study. JCM 2018;7:252
Tahmina Lata, Jodie Trautman, Philip Townend, Robert B Wilson. Current management of gastro-oesophageal reflux disease—treatment costs, safety profile, and effectiveness: a narrative review. 2022;11
Na Li, Guoqin Zhang, Xueyan Zhang, Yi Liu, Yan Kong, Meng Wang, Xiaoliang Ren. A rapid-floating natural polysaccharide gel–raft with double-effect for the treatment of gastroesophageal reflux disease. International Journal of Biological Macromolecules 2024;261:129667
Rachel Gingold‐Belfer, Yichayaou Beloosesky, Amir Amara, Eran Sharon, Doron Boltin, Nira Koren‐Morag, Joseph Meyerovitch, Hemda Schmilovitz‐Weiss. Different effects of chronic omeprazole use on osteoporotic fractures rate in the elderly. Brit J Clinical Pharma 2023;89:3539
Cheol Min Shin, Nayoung Kim, Yong Sung Kim, Ryoung Hee Nam, Ji Hyun Park, Dong Ho Lee, Yeong-Jae Seok, Yeon-Ran Kim, Joo-Hyon Kim, Jung Min Kim, Joo Sung Kim, Hyun Chae Jung. Impact of Long-Term Proton Pump Inhibitor Therapy on Gut Microbiota in F344 Rats: Pilot Study. Gut and Liver 2016;10:896
Paul Schadler, Birgit Lohberger, Nicole Stündl, Martin Helmut Stradner, Dietmar Glänzer, Patrick Sadoghi, Andreas Leithner, Bibiane Steinecker-Frohnwieser. The Effect of Body Mass Index and Metformin on Matrix Gene Expression in Arthritic Primary Human Chondrocytes. CARTILAGE 2021;13:1004S
Ziping Cheng, Yangjie Liu, Mengyuan Ma, Shiyu Sun, Zengqing Ma, Yu Wang, Liyuan Yu, Xuping Qian, Luning Sun, Xuehui Zhang, Yun Liu, Yongqing Wang. Lansoprazole-induced osteoporosis via the IP3R- and SOCE-mediated calcium signaling pathways. Mol Med 2022;28
Miyoung Ock, Sera Lee, Hyunah Kim. Osteoporosis or fracture risk associated with thiazolidinedione and proton pump inhibitor co‐administration in patients with type 2 diabetes mellitus. Clinical Pharmacy Therapeu 2022;47:1028
Sophia Ogechi Ekeuku, Benjamin Ka Seng Thong, Adam Quraisiah, Fazalda Annuar, Alfizah Hanafiah, Mohd Fahami Nur Azlina, Kok-Yong Chin.
The Skeletal Effects of Short-Term Triple Therapy in a Rat Model of Gastric Ulcer Induced by Helicobacter pylori Infection
. DDDT 2020;Volume 14:5359
Claire J Steves, Sarah Bird, Frances MK Williams, Tim D Spector. The Microbiome and Musculoskeletal Conditions of Aging: A Review of Evidence for Impact and Potential Therapeutics. 2016;31:261
Roger Zebaze, Peter Robert Ebeling. Disorganization and Musculoskeletal Diseases: Novel Insights into the Enigma of Unexplained Bone Abnormalities and Fragility Fractures. Curr Osteoporos Rep 2023;21:154
Yichao Shi, Jianfeng Li, Shuntian Cai, Hong Zhao, Huijun Zhao, Gang Sun, Yunsheng Yang. Proton pump inhibitors induced fungal dysbiosis in patients with gastroesophageal reflux disease. Front. Cell. Infect. Microbiol. 2023;13
Md. Saddam Hussain, Tanoy Mazumder. Long-term use of proton pump inhibitors adversely affects minerals and vitamin metabolism, bone turnover, bone mass, and bone strength. 2022;33:567
Bjarne Nesgaard Andersen, Per Birger Johansen, Bo Abrahamsen. Proton pump inhibitors and osteoporosis. 2016;28:420
Bhavneet K. Chawla, Robert E. Cohen, Elizabeth M. Stellrecht, Lisa M. Yerke. The influence of proton pump inhibitors on tissue attachment around teeth and dental implants: A scoping review. Clinical & Exp Dental Res 2022;8:1045
Cristóbal de la Coba Ortiz, Federico Argüelles Arias, Carlos Martín de Argila de Prados, Javier Júdez Gutiérrez, Antonio Linares Rodríguez, Aida Ortega Alonso, Enrique Rodríguez de Santiago, Manuel Rodríguez-Téllez, María Isabel Vera Mendoza, Lara Aguilera Castro, Ángel Álvarez Sánchez, Raúl Jesús Andrade Bellido, Fidencio Bao Pérez, Manuel Castro Fernández, Froilán Giganto Tomé. Proton-pump inhibitors adverse effects: a review of the evidence and position statement by the Sociedad Española de Patología Digestiva. Rev Esp Enferm Dig 2016;108:207
Hajer A. Aldulaijan. Impact of proton pump inhibitors on periodontal health – A systematic review. The Saudi Dental Journal 2024;36:1160
R. Jun Lin, Shaum Sridharan, Libby J. Smith, VyVy N. Young, Clark A. Rosen. Weaning of proton pump inhibitors in patients with suspected laryngopharyngeal reflux disease. The Laryngoscope 2018;128:133
Yohannes T. Ghebre. Proton Pump Inhibitors and Osteoporosis: Is Collagen a Direct Target?. Front. Endocrinol. 2020;11
Yu Chang, Chih-Yuan Huang, Ming-Tsung Chuang, Kuan-Yu Chi, Junmin Song, Hong-Min Lin. The Impact of Proton Pump Inhibitor Use on Fusion Rates Following Single-level Anterior Cervical Discectomy and Fusion. 2024
Negar Kanounisabet, Ahmad Mogharehabed, Nakisa Torabinia, Seyedeh Marzieh Hashemi Nejad, Jaber Yaghini. Effect of systemic administration of omeprazole on osseointegration around titanium dental implants. 2021;18:43
Fang-Fang Jiang, Yu Guo, Zheng Zhang, Sun-Jun Yin, Yu-Xin Fan, Yan-Hua Huang, Ya-Jia Li, Li-Rong Chen, Kai Qian, Gong-Hao He. The benefit of omeprazole exposure on all-cause mortality and length of ICU/hospital stay might vary with age in critically ill pediatric patients: A cohort study. Eur J Clin Pharmacol 2024;80:115
Chandan Vangala, Jingbo Niu, Colin R. Lenihan, William E. Mitch, Sankar D. Navaneethan, Wolfgang C. Winkelmayer. Proton Pump Inhibitors, Histamine-2 Receptor Antagonists, and Hip Fracture Risk among Patients on Hemodialysis. CJASN 2018;13:1534
Sneha Teresa Selvin, Sonu Thomas, Viktoriya Bikeyeva, Ahmed Abdullah, Aleksandra Radivojevic, Anas A Abu Jad, Anvesh Ravanavena, Chetna Ravindra, Emmanuelar O Igweonu-Nwakile, Safina Ali, Salomi Paul, Shreyas Yakkali, Prachi Balani. Establishing the Association Between Osteoporosis and Peptic Ulcer Disease: A Systematic Review. 2022
Andreas Kommer, Karel Kostev, Eva Maria Schleicher, Julia Weinmann-Menke, Christian Labenz. Proton pump inhibitor use and bone fractures in patients with chronic kidney disease. 2024;40:173